Monotherapy in adults and elderly persons
Author:
- 11 December 2007
- journal article
- review article
- Published by Wolters Kluwer Health in Neurology
- Vol. 69 (24_suppl_3) , S3-S9
Abstract
Treatment of epilepsy with a single drug has many advantages. Potential benefits of monotherapy vs polytherapy include fewer adverse events and better tolerability, avoidance of drug-drug interactions, reduced treatment costs, and improved compliance. Initial treatment should always be monotherapy. Avoidance of pharmacokinetic interactions is a major advantage. Some patients who have achieved seizure control with polytherapy may be candidates for conversion to monotherapy because there is no conclusive evidence that polytherapy provides better seizure control in the majority of patients. Recently published treatment guidelines that take into account the efficacy and tolerability profiles of new and old antiepileptic drugs (AEDs) provide recommendations for drug selection in adults. Elderly patients with epilepsy face unique treatment challenges, which include age-related reductions in liver or kidney function that may alter drug pharmacokinetics. Older persons are more sensitive to CNS side effects; some drugs may exacerbate preexisting problems such as tremor, ataxia, and cognitive difficulty. Many common conditions in the elderly are treated with drugs that are subject to interactions with AEDs. Complex dosing schedules and high drug costs are often barriers to proper care. For all these reasons, monotherapy is especially attractive for the elderly.Keywords
This publication has 20 references indexed in Scilit:
- A New Look at the Second-Generation Antiepileptic DrugsThe Neurologist, 2007
- ILAE Treatment Guidelines: Evidence‐based Analysis of Antiepileptic Drug Efficacy and Effectiveness as Initial Monotherapy for Epileptic Seizures and SyndromesEpilepsia, 2006
- Complaints associated with the use of antiepileptic drugs: results from a community-based studySeizure: European Journal of Epilepsy, 2005
- Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy [RETIRED]Neurology, 2004
- Monotherapy versus Polytherapy in EpilepsyCNS Drugs, 1995
- Seizure Disorders: The Changes With AgeEpilepsia, 1992
- The Substantia Nigra is an Important Site for the Containment of Seizure Generalization in the Kindling Model of EpilepsyEpilepsia, 1987
- High‐dose monotherapy in treatment of intractable seizuresNeurology, 1984
- REDUCTION OF POLYPHARMACY FOR EPILEPSY IN AN INSTITUTION FOR THE RETARDEDDevelopmental Medicine & Child Neurology, 1983
- Monotherapy or Poly therapy for Epilepsy?Epilepsia, 1981